Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CPB1 | P15086 | 2/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | GAA | P10253 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | SYK | P43405 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | CCR2 | P41597 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | KDM1A | O60341 | 1/20 | 0.41 |
| ▸ | MAOB | P27338 | 1/20 | 0.41 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.41 |
| ▸ | TACR1 | P25103 | 2/20 | 0.41 |
| ▸ | CTSL | P07711 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL714949 | 1.00 | CPB1 (0.53) | CPB1ALDH1A1GAATSHRSYK | |
| SCHEMBL713199 | 1.00 | CPB1 (0.53) | CPB1ALDH1A1GAATSHRSYK | |
| SCHEMBL716516 | 1.00 | CPB1 (0.53) | CPB1ALDH1A1GAATSHRSYK | |
| SCHEMBL715808 | 1.00 | CPB1 (0.53) | CPB1ALDH1A1GAATSHRSYK | |
| SCHEMBL4265690 | 0.93 | CPB1 (0.55) | CPB1ALDH1A1GAATSHRSYK | |
| SCHEMBL715267 | 0.92 | CPB1 (0.60) | CPB1ALDH1A1GAATSHRSYK | |
| SCHEMBL714564 | 0.92 | CPB1 (0.60) | CPB1ALDH1A1GAATSHRSYK | |
| SCHEMBL1504068 | 0.89 | ALDH1A1 (0.58) | CPB1ALDH1A1GAATSHRSYK | |
| SCHEMBL10476662 | 0.89 | ALDH1A1 (0.58) | CPB1ALDH1A1GAATSHRSYK | |
| SCHEMBL4271202 | 0.88 | TSHR (0.60) | CPB1ALDH1A1GAATSHRSYK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120053349-A1 | OXAMIDE DERIVATIVE | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2012-03-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120053349-A1 | OXAMIDE DERIVATIVE | SULT1E1, PKD2, PKD1 | CPB1 2328/4885ALDH1A1 299/4885GAA 3639/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.